ERBB2 and breast carcinoma: The percentages of peripheral blood macrophages with neither (a) the PM-2 K+CD14+ expression profile nor (b) the PM-2 K+CD14− expression profile were significantly different between patients with HER2-positive breast cancer and those with HER2-negative breast cancer.